Quantinno Capital Management LP Has $5.58 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY)

Quantinno Capital Management LP increased its position in Revvity, Inc. (NYSE:RVTY - Free Report) by 62.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 43,692 shares of the company's stock after acquiring an additional 16,834 shares during the period. Quantinno Capital Management LP's holdings in Revvity were worth $5,582,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of RVTY. Rothschild Investment LLC acquired a new position in Revvity during the 2nd quarter worth $25,000. Gladius Capital Management LP acquired a new stake in Revvity in the third quarter worth about $32,000. EverSource Wealth Advisors LLC grew its position in Revvity by 74.2% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 392 shares of the company's stock valued at $41,000 after buying an additional 167 shares in the last quarter. Avior Wealth Management LLC increased its stake in Revvity by 7,980.0% during the 3rd quarter. Avior Wealth Management LLC now owns 404 shares of the company's stock valued at $52,000 after buying an additional 399 shares during the period. Finally, Fairfield Financial Advisors LTD bought a new stake in shares of Revvity during the 2nd quarter worth about $43,000. Institutional investors and hedge funds own 86.65% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Raymond James boosted their price objective on Revvity from $144.00 to $146.00 and gave the stock an "outperform" rating in a research note on Tuesday, November 5th. Wells Fargo & Company started coverage on Revvity in a report on Tuesday, August 27th. They issued an "equal weight" rating and a $130.00 price target on the stock. Barclays cut their price objective on Revvity from $140.00 to $135.00 and set an "overweight" rating for the company in a research report on Monday, November 25th. Sanford C. Bernstein decreased their target price on Revvity from $150.00 to $145.00 and set an "outperform" rating on the stock in a report on Tuesday, November 5th. Finally, Leerink Partners upped their target price on Revvity from $130.00 to $135.00 and gave the company an "outperform" rating in a report on Thursday, October 17th. Seven equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $131.73.

Revvity Stock Up 1.2 %

Shares of NYSE:RVTY traded up $1.37 on Friday, reaching $116.46. The company had a trading volume of 709,615 shares, compared to its average volume of 921,991. The company has a quick ratio of 2.97, a current ratio of 3.56 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $14.17 billion, a P/E ratio of 56.26, a P/E/G ratio of 3.57 and a beta of 1.03. The stock has a 50-day moving average price of $118.87 and a 200 day moving average price of $116.23. Revvity, Inc. has a twelve month low of $88.90 and a twelve month high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.28 earnings per share for the quarter, topping analysts' consensus estimates of $1.13 by $0.15. The business had revenue of $684.10 million during the quarter, compared to analysts' expectations of $679.66 million. Revvity had a net margin of 9.34% and a return on equity of 7.42%. Revvity's revenue for the quarter was up 2.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.18 earnings per share. On average, equities analysts expect that Revvity, Inc. will post 4.85 EPS for the current year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 7th. Stockholders of record on Friday, January 17th will be given a $0.07 dividend. The ex-dividend date of this dividend is Friday, January 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.24%. Revvity's dividend payout ratio is 13.53%.

Revvity declared that its board has initiated a stock repurchase program on Monday, November 4th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to repurchase up to 6.5% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board of directors believes its stock is undervalued.

Insider Transactions at Revvity

In other Revvity news, insider Tajinder S. Vohra sold 2,153 shares of the company's stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $122.09, for a total value of $262,859.77. Following the completion of the transaction, the insider now owns 23,960 shares of the company's stock, valued at $2,925,276.40. This represents a 8.24 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.60% of the stock is currently owned by corporate insiders.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.